Today's 8k is huge news for the company and, even on the high volume today, has not been seen or grapsed by the market.
In plain English, they are receiving a massive cash infusion to greatly accelerate growth in China. There will be some dilution at the China subsidiary level, but not at the REMI level. Remedent will never need cash again.
Accel plainly see the company is way undervalued. Hence, their willingness to invest a very large sum.
The branch of Accel is the China fund. Knowing how things work in China, I think this will greatly help with obtaining licensing.
I expect REMI will be having a CC to better explain things.
Make no mistake, this is a very positive development. Existing stores will receive more advertising. They were previously cash-flow constrained and operating at less than 1/3 capacity. Second the capital investment required for new stores is now available.